DNA Shed by Colon Cancers May Help Oncologists Personalize Postsurgical Treatment

A new international study co-led by Johns Hopkins researchers shows that measuring circulating tumor DNA (ctDNA) can help personalize treatment for patients with Stage 3 colon cancer.

APRENDE MÁS

VER TODAS LAS NOTICIAS

Mensajes recientes

Elena’s Story: Recurrent Brain Cancer After a year of turmoil, cancer researchers see promising signs for mRNA vaccines AI and Mammograms Single Nutrient Fuels Cancer-Fighting Power of T Cells Alcohol and Cancer Risk Colon Cancer Screening: What You Need to Know Detecting Early-Stage Cancers with a New Blood Test Measuring Epigenetic Instability Oral Bacterium May Promote Breast Cancer Development and Spread Extra Copies of Chromosome 1q May Drive Pancreatic Cancer